choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Boehringer Ingelheim FDA

Boehringer Ingelheim FDA Newsletter
  • FTC claims a win as Teva moves to delist hundreds of patents from FDA Orange Book, agency says 11 Dec 2025 03:11 GMT

    … improper" patents in an FDA registry, a practice the agency … more than 200 patents from FDA records, according to a Dec … said. The removals from the FDA's Orange Book … the likes of AbbVie, AstraZeneca, Boehringer Ingelheim, GSK, Teva, Novo Nordisk and …

  • Finerenone reduces albuminuria in adults with type 1 diabetes 12 Dec 2025 15:57 GMT

    … for Alexion, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Dimerix, Eli Lilly, Novartis, Novo … support from AstraZeneca, Bayer, Boehringer Ingelheim, Novo Nordisk and travel support … guidelines Clinical Guidance, Healio CME, FDA news Healio's exclusive …

  • Manage obesity with evidence-based solutions 12 Dec 2025 15:57 GMT

    … reports consulting for Amgen, Bayer, Boehringer Ingelheim, Eli Lilly, Jazz, Medtronic, … steering committee member for Arrowhead, Boehringer Ingelheim, Cleerly Health, Medtronic, Novartis … Clinical Guidance, Healio CME, FDA news Healio's exclusive …

  • Nimacimab plus semaglutide safe, confers significant weight loss 12 Dec 2025 15:57 GMT

    … reports advising for Altimmune, Atria, Boehringer Ingelheim, CinFina Pharma, Corteria, Eli Lilly … , guidelines Clinical Guidance, Healio CME, FDA news Healio's exclusive …

  • Rx Rundown: Pfizer, Mirum Pharmaceuticals, Novartis and more 11 Dec 2025 22:38 GMT

    … Regional Medical Center. FDA: The FDA launched a safety review … to treat thalassemia. The FDA announced it will host … severe aplastic anemia. The FDA approved the first AI … untreatable mosquito-borne disease. Boehringer Ingelheim unveiled more details about a …

  • GRI Bio’s tazarotene achieves Phase IIa IPF success 11 Dec 2025 16:03 GMT

    … -owned Genentech’s Esbriet and Boehringer Ingelheim’s Ofev being the last … US Food and Drug Administration (FDA) in October 2025 – making it … . Meanwhile, United Therapeutics is seeking FDA approval for Tyvaso (inhaled treprostinil …

  • First OX40 inhibitor has disease modification potential for eczema 11 Dec 2025 16:09 GMT

    … Biotherapeutics, Artax Biopharma, Astria Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Celldex Therapeutics … , guidelines Clinical Guidance, Healio CME, FDA news Healio's exclusive …

  • Pfizer's $2bn+ obesity bet, and other weight-loss news 11 Dec 2025 12:23 GMT

    … various phase 3 results with Boehringer Ingelheim-partnered GLP-1/glucagon … -phase 2 meeting with the FDA in the first quarter of … to current weight-loss drugs. Boehringer Ingelheim said this week it will …

  • Tucatinib combo improves PFS in breast cancer subset 10 Dec 2025 21:38 GMT

    … from AbbVie, Arvinas, AstraZeneca, BeiGene, Boehringer Ingelheim, Bristol Myers Squib, Daiichi Sankyo … , guidelines Clinical Guidance, Healio CME, FDA news Healio's exclusive …

  • JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China 10 Dec 2025 10:35 GMT

    … .S. Food and Drug Administration (FDA) for IPF after securing Priority … under priority review by the FDA for the treatment of adults … approvals anticipated in 2026. About Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company active …

Satisfied with the content?

Continue to create your account.